Connection

Paolo Gisondi to Interleukin-17

Back to Details
This is a "connection" page, showing publications Paolo Gisondi has written about Interleukin-17.
Paolo Gisondi
Connection Strength
0.198
Interleukin-17
  1. Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis. Clin Exp Rheumatol. 2019 Jan-Feb; 37(1):133-136.
    View in: PubMed
    Score: 0.130
  2. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
    View in: PubMed
    Score: 0.038
  3. Effects of secukinumab on serum adipocytokines: preliminary data. Reumatismo. 2017 Sep 21; 69(3):105-110.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.